Vera Therapeutics Q1 2026 Earnings EPS Miss Highlights PreRevenue Stage Challenges STRRP Q1 2026 Earnings Missed Estimates with Significant EPS Shortfall GNK Q1 2026 Earnings Massive EPS Beat of 3429 Surprises Market ADNT Q1 2026 Earnings EPS Surpasses Estimates by 172 on Strong Operational Execution WRLD Q1 2026 Earnings EPS Misses Estimates Amid Mixed Credit Trends Stock Edges Higher YDKG Q4 2012 Earnings EPS Misses Estimates as Stock Rises on Strategic Progress